Table 3 Univariate analyses of 102 women with 2018 FIGO stage IIIC1p cervical cancer with regard to OS and DFS

Age (reference: ≤ 54)

0.738(0.375 ~ 1.454)

0.688(0.351 ~ 1.350)

Postoperative treatment (reference: none)

-

-

 Chemotherapy

0.327(0.152 ~ 0.705)

0.381(0.177 ~ 0.821)

 Chemo plus radiotherapy

0.061(0.024 ~ 0.157)

0.078(0.031 ~ 0.197)

Surgical method (reference: laparoscope)

0.760(0.353 ~ 1.636)

0.695(0.319 ~ 1.515)

Ovarian status (reference: ovarian transposition)

2.585(1.090 ~ 6.130)

2.388(1.060 ~ 5.381)

Intraoperative blood loss (ml) (reference: ≤ 250)

1.690(0.911 ~ 3.134)

1.588(0.861 ~ 2.927)

Perioperative complications (reference: none)

2.277(1.249 ~ 4.150)

2.102(1.159 ~ 3.813)

Pathological type (reference: squamous cell carcinoma)

-

-

 Adenocarcinoma

1.197(0.555 ~ 2.581)

1.098(0.511 ~ 2.359)

 Adeno-squamous carcinoma

1.276(0.392 ~ 4.158)

1.185(0.364 ~ 3.851)

Tumor size (cm) (reference: ≤ 4)

1.564(0.875 ~ 2.796)

1.519(0.861 ~ 2.679)

LNR (reference: ≤ 0.3)

4.643(2.572 ~ 8.381)

4.490(2.505 ~ 8.050)

DSI (reference: ≤ 1/2)

3.208(0.774 ~ 13.294)

3.620(0.866 ~ 15.136)

LVSI (reference: negative)

2.283(1.192 ~ 4.371)

2.013(1.070 ~ 3.787)

Vaginal margin (reference: negative)

1.607(0.901 ~ 2.866)

1.507(0.853 ~ 2.663)

Parametrium (reference: negative)

2.381(1.108 ~ 5.113)

2.621(1.264 ~ 5.434)

NLR (reference: ≤ 3.8)

2.694(1.357 ~ 5.349)

3.397(1.745 ~ 6.612)